Other languages Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-02 pm EDT			5-day change	1st Jan Change
1.92 ^USD	+3.23%		+9.09%	+10.34%

Mar. 11	Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street	MT
Mar. 11	Top Premarket Gainers	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Traders Anticipate Inflation Report as US Equities Open Lower on Wall Street	Mar. 11
Top Premarket Gainers	Mar. 11
Sonnet BioTherapeutics Holdings, Inc. Announces First Phase 1b/2a Clinical Trial of SON-080	Mar. 11
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 14
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 14
Sector Update: Health Care Stocks Retreating Late Afternoon	23-10-25
Top Midday Decliners	23-10-25
Top Premarket Decliners	23-10-25
Sector Update: Health Care Stocks Lower in Late Afternoon Trading	23-08-31
Sector Update: Health Care Stocks Lower Thursday Afternoon	23-08-31
Sonnet BioTherapeutics to Implement 1-for-22 Reverse Stock Split; Shares Fall	23-08-31
Sector Update: Health Care Stocks Decreasing Late Afternoon	23-08-16
Sector Update: Health Care Stocks Lower Wednesday Afternoon	23-08-16
Sector Update: Health Care	23-08-16
Top Midday Gainers	23-08-16
Sonnet BioTherapeutics Says FDA Accepts IND for Trial of Ovarian Cancer Treatment; Shares Jump	23-08-16
Sonnet Biotherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the US	23-08-16
Sonnet BioTherapeutics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-14
Sonnet BioTherapeutics to Raise $2.3 Million in Registered Direct Offering, Private Placement; Shares Fall	23-06-28
Sonnet Biotherapeutics Holdings, Inc. Announces Regulatory Approval for Initiation of A Clinical Trial of Son-1010 Combined with Atezolizumab	23-06-20

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sonnet BioTherapeutics Holdings, Inc.

Equities

SONN

US83548R3030

Other languages

Filters